Dr. Christopher Charles Foote, DO

Dr. Foote practices at Central Maine Medical Center in Lewiston, Maine, part of Prime Healthcare Services.

Dr. Foote's NPI, 1912310442, was assigned on June 2, 2014. Dr. Foote graduated from Philadelphia College of Osteopathic Medicine in 2014. Dr. Foote holds Maine license DO3032.

Dr. Foote's primary practice is Central Maine Medical Center, at 300 Main Street, Lewiston, ME 04240 in Androscoggin County. The practice phone is (207) 795-0111.

Dr. Foote's primary practice is Central Maine Medical Center in Lewiston, Maine, part of Prime Healthcare Services. Dr. Foote is also affiliated with Bridgton Hospital. The medical group on file is Central Maine Medical Center. Dmand AI also links Dr. Foote to 1 more hospital, 3 medical groups and 2 group practices and clinics, each named with a free account. Dr. Foote's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Foote practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Foote's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Foote's licenses on file in 3 states: Maine, Pennsylvania and South Carolina.

CMS data shows 334 Medicare services from Dr. Foote across 9 procedure codes in 2024, for 167 Medicare patients. Medicare paid $19,159 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 167 Medicare patients who saw Dr. Foote in 2024. The largest group is 65 to 74, with 71 patients. 69% of them have high blood pressure, and 67% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Foote's median patient age at 71, with 25% women.

In 2024, Dr. Foote wrote 843 Medicare Part D claims for 279 patients. 90% of them were for generic drugs. CMS names the drug for 754 of them, across 11 drugs with 11 or more claims each, at $42,096 in total drug cost. In 2023, CMS named 715 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Foote for performance year 2024, reported as part of a group. Dr. Foote accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Foote as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Foote, published from 2014 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Penile Prosthesis. Dr. Foote has published most often in J Sex Med. Dr. Foote's most frequent co-authors are Claudia Alejandra Alvarez, DO, John Denis Berne, MD and Ryan P. Dumas, MD.

CMS Open Payments shows 121 general payments to Dr. Foote from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Axonics, Inc. paid the most, $970.

Dr. Foote graduated from Philadelphia College of Osteopathic Medicine in 2014.